Select Medical Technology and Devices Portfolio
Actively managed U.S. stock fund
As of its 2026 Q2 report, Select Medical Technology and Devices Portfolio held 66 positions with $2.98B in net assets. Its ten largest holdings made up 63.5% of the fund. The FSMEX share class costs 0.62% a year. Over the 12 months to May 2026, FSMEX lost 10.2%, with dividends reinvested. In 2026 Q2 it added 10 new positions and exited 10.
Medical Technology and Devices Portfolio seeks capital appreciation.
The fund invests at least 80% of assets in common stocks of companies principally engaged in medical device and equipment manufacturing, drug discovery services, or health care information technology, using fundamental analysis of financial condition and industry position. The fund may invest in both domestic and foreign issuers. Because the fund's classification of companies as principally engaged in these activities relies on asset, income, sales, or profit metrics or third-party industry classifications, the fund's holdings may diverge from what different analysts would consider the core medical technology sector.
What you own
| Company | Weight | Value | Shares | Reported price |
|---|---|---|---|---|
DHRDANAHER CORP | 15.09% | $449.37M | 2.5M | $182.67 |
14.06% | $418.63M | 850.0K | $492.51 | |
7.45% | $221.87M | 522.5K | $424.64 | |
5.11% | $152.18M | 3.1M | $48.31 | |
4.21% | $125.38M | 1.4M | $86.47 | |
SYKSTRYKER CORP | 4.18% | $124.48M | 408.0K | $305.09 |
3.85% | $114.70M | 1.3M | $85.60 | |
WATWATERS CORP | 3.27% | $97.43M | 254.0K | $383.57 |
3.21% | $95.70M | 706.1K | $135.53 | |
3.09% | $92.00M | 285.0K | $322.81 |
Reported price is the fund's own reported value divided by its own reported shares at 2026-05-31 — not a live quote, and not what the fund paid.
All 66 holdings, with the share counts as filed, open with a free account.
What the fund is made of
Percentages are of fund net assets. Rounding, liabilities and short positions can make totals differ from 100%.
| Stocks | 99.52% |
| Cash & short-term | 3.37% |
| Bonds | 0.04% |
By sector
- Health Care
- 91.5%
- Cash
- 3.3%
- Other
- 2.7%
- International
- 2.5%
How it has done
FSMEX share class · total returns with dividends reinvested
Volatility over the last 12 months: 15.14%. Past returns are a record, not a forecast.
Fees & fund details
Select Medical Technology and Devices Portfolio is an actively managed U.S. equity fund. 13% of FSMEX’s stock holdings are in companies whose revenue grew in the top quartile of U.S. companies over the last five fiscal years (covering 92% of the fund’s equity).
- Asset class
- Equity
- Region
- United States
- Management
- Actively managed
- Fund type
- Open-end fund
- Features
- Non-diversified
- Expense ratio, by class
- 0.62%· FSMEX 0.62%
- Portfolio turnover
- 54.00% a year · as of 2026 Q2
Turnover is how much of the portfolio was replaced in a year.
Classified from what the fund holds, not from its name · 2026 Q2. The summary is a paraphrase of the prospectus; the objective is verbatim.
What changed this quarter
Positions that entered or left the fund since its previous filing. Positions that were only resized are not listed.
10 new· the largest 8
10 exited· the largest 8
Debt profile
What this fund holds — value-weighted across its bond and securitized long positions · as of 2026-05-31
Share of the fund's debt by how its coupon behaves — the fact that decides whether a rate move reaches this portfolio at all.
| Fixed rate | 100.0% |
Share of the fund's debt value in each maturity band, shortest first.
| <1y | 100.0% |
Based on what filers reported; a filer that never reported a flag also reads as none.
Understand how this fund fits with the rest.
Explore shared holdings, compare funds and follow their businesses with your connected AI:
- “Where do my funds overlap — FSMEX, QQQ and the fund in my 401(k)?”
- “How do this fund’s ten biggest holdings stack up against each other?”
- “For my target-date fund, what’s the real stock-and-bond mix once you look through it?”